- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01197872
Clinical Use of Parental Support To Detect Single Gene Mutations
Phase II: Clinical Use of Parental Support To Detect Single Gene Mutations
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study follows previous IRB approved study IVF008: Clinical Use of Parental Support To Detect Single Gene Mutations , which we will refer to as "Phase I".
The purpose of Phase I was to validate clinical use of PS to detect specific genetic mutation(s) known to cause severe inheritable diseases in embryos produced by at-risk couples, while simultaneously testing these embryos for aneuploidy. The Phase I study consisted of first of its kind PGS/D testing to detect disease-associated genetic mutations together with aneuploidy screening.
This study, which we will call "Phase II", will allow patients to continue to access testing while clinical data is collected on Phase I. Phase I of the study is nearing enrollment targets (40+ participating couples) and Phase I enrollment will be closed while subjects complete testing and study data is collected from pregnancies and livebirths. Phase II will allow: 1) additional data collection prior to commercial testing launch, 2) eligible patients to participate and receive testing.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
California
-
Redwood City, California, United States, 94063
- Gene Security Network
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
At risk couple (mother and father) who are:
- Able to provide laboratory report from commercial CLIA certified laboratory in the United States or legitimate non-US laboratory confirming presence of disease associated mutation in mother and/or father
- Planning to go through IVF and desiring PGD for the specified mutation
- Planning to pursue Chorionic Villus Sampling (CVS) or Amniocentesis if pregnancy occurs and willing/able to provide CVS/ Amniocentesis sample to GSN for confirmatory testing or provide test results of confirmatory testing performed by an external laboratory.
Exclusion Criteria:
- Couples without prior documentation of genetic mutation as specified above
- Couples where the male partner is not willing, able, or available to provide a semen sample
- Unwilling to have CVS/ Amniocentesis
- In certain cases, unavailability of child sample or other suitable family member: Subjects will not be able to enroll in the study if, in the judgment of the research staff, validation is first required on a child (offspring of male and female subject) and there is no child or other family member that is a suitable substitute available for testing.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Confirmation of diagnosis through prenatal diagnosis
Time Frame: 10-20 weeks post intervention
|
Confirmation of PGS test results through prenatal diagnosis
|
10-20 weeks post intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Matthew Rabinowitz, PhD, CEO, Gene Security Network
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IVF008.5
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Single Gene Disorders
-
Cervesi Hospital, Cattolica, ItalyRecruiting
-
Cervesi Hospital, Cattolica, ItalyUnknown
-
Imperial College London Diabetes CentreUnknownMendelian Disorders | Genetic Disorder | Novel Mutation | Hereditary Disorder | De Novo Mutation | Inherited Disease | Single-Gene DefectsUnited Arab Emirates
-
GenEmbryomics Pty. LtdRecruitingFertility Issues | Single-Gene DefectsUnited States, Turkey
-
Beijing Tiantan HospitalBeijing Municipal Science & Technology CommissionCompletedTransient Ischemic Attack | Stroke, Acute | Single-gene DisordersChina
-
Catholic University of the Sacred HeartUnknownRetinal Degeneration | Genetic Disease | Single-Gene Defects | Macular DystrophyItaly
-
Teesside UniversityCompletedSingle Leg Hop Sand Surface | Single Leg Hop Grass Surface | Single Leg Hop Firm SurfaceUnited Kingdom
-
Centre Leon BerardRecruitingCancer | Cancer Metastatic | ALK Fusion Protein Expression | FGFR2 Gene Translocation | FGFR3 Gene Translocation | NTRK Family Gene Mutation | Gene Fusion | ROS1 Gene Translocation | NTRK Gene Fusion Overexpression | ATIC-ALK Fusion Protein Expression | BCR-FGFR1 Fusion Protein Expression | COL1A1-PDGFB Fusion... and other conditionsFrance, Denmark, Netherlands, Austria, Germany, Italy, United Kingdom, Czechia, Poland, Slovenia, Spain
-
National Cancer Institute (NCI)CompletedBRCA1 Gene | BRCA2 GeneUnited States
-
Marc Dall'Era, MDNational Cancer Institute (NCI); Janssen, LPRecruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Prostate Carcinoma | RAD51C Gene Mutation | BRIP1 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CDK12 Gene Mutation | CHEK1 Gene Mutation | DNA Damage Response Gene Mutation | DNA Repair Gene Mutation | FANCA Gene Mutation and other conditionsUnited States
Clinical Trials on Preimplantation Genetic Diagnosis
-
ReprogeneticsSuspendedInfertilityUnited States, Spain
-
Reproductive & Genetic Hospital of CITIC-XiangyaCompletedThalassemia,Embryonic Development,Reproductive Sterility and InfertilityChina
-
Changlin MeiThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsCompletedPolycystic Kidney, Type 1 Autosomal Dominant DiseaseChina
-
ReprogeneticsMcGill University; Yale University; Reprogenetics, Livingston, NJ; Long Island... and other collaboratorsSuspendedInfertility | Recurrent Pregnancy LossUnited States
-
ReprogeneticsMcGill University; Yale University; Reprogenetics Lationoamerica S.A.C, Lima,... and other collaboratorsTerminatedInfertility | MiscarriagePeru
-
ReprogeneticsReproductive Medicine Lab, LLCUnknown
-
ReprogeneticsMain Line Fertility CenterUnknownInfertility | Recurrent Pregnancy LossUnited States
-
Natera, Inc.Ferring PharmaceuticalsTerminatedIn Vitro Fertilization (IVF) | Preimplantation Genetic Diagnosis (PGD) | Preimplantation Gentic Screening (PGS)United States
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
Genomic Prediction Inc.RecruitingInfertility, FemaleUnited States